partnering
Partnering is an integral component of Allozyne’s strategy to maximize the value of its technology, generate near- and mid-term revenue and speed the development of new therapies for patients with unmet medical need.
Allozyne seeks to collaborate with leading biotechnology and pharmaceutical companies by leveraging its robust platform technology to protein and peptide therapies will yield enhanced therapies which have substantial clinical and commercial potential. We also seek opportunities to in-license rights to novel proteins and peptides to develop as proprietary products.
Companies interested in exploring partnering opportunities with Allozyne should contact bd@allozyne.com.